Researchers from the Howard Hughes Medical Institute's Janelia Farm Research Campus have demonstrated that the principal neuronal type of the hippocampus, the pyramidal neuron, comes in two distinct flavors that may process different types of information. Read More
Six weeks of positive results in Phase III trials with the fixed-dose combination (FDC) of perindopril arginine with amlodipine besylate for high blood pressure should be enough – when packaged with data from overseas, where it's marketed already as Coveram – to justify a new drug application (NDA), said XOMA Corp. Read More
While searching for mechanisms of resistance to one targeted cancer therapy, researchers have identified a signaling mechanism that can lead to resistance to multiple targeted and chemotherapy cancer drugs alike. Read More
Spun out in 2006 from French diagnostics firm BioMérieux SA with the help of Swiss bioincubator Eclosion, GeNeuro SA has slowly but steadily progressed its monoclonal antibody (mAb) technology – initially to prevent the inflammatory and autoimmune cascades induced by the multiple sclerosis-associated retrovirus (MSRV). Read More
• Evolva Holding SA, of Allschwil, Switzerland, will acquire assets owned by Danish firm Fluxome Sciences A/S, subject to creditor and court approval. The transaction will not alter Evolva's financial projections for 2012. Read More
BioWorld's offices were closed Thursday, Nov. 22, and Friday, Nov. 23, in observance of the Thanksgiving Day holiday in the U.S. No issues were published those days. Read More
• MediciNova Inc., of San Diego, started enrolling a Phase IIa trial testing MN-166 (ibudilast) in prescription opioid or heroin abusers. The trial will be conducted at Columbia University and the New York State Psychiatric Institute and is funded by the National Institutes for Drug Abuse. Read More
• Novartis AG, of Basel, Switzerland, gained FDA approval of Flucelvax, described as the first cell culture-derived seasonal flu vaccine cleared for marketing in the U.S. The vaccine was approved for adults 18 years old and older. Read More
